Accessibility Menu
Apexigen logo

Apexigen

(NASDAQ) APGN

Current PriceN/A
Market CapN/A
Since IPO (2021)-96%
5 YearN/A
1 Year-93%
1 Month-12%

Apexigen Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$26.66M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

APGN News

No articles available.

APGN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Apexigen

Industry

Biotechnology

Employees

20

CEO

Sam P. Wertheimer, PhD

Headquarters

San Carlos, CA 94070, US

APGN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

48%

Return on Capital

-5%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$32.69M

EBITDA

$32.58M

Operating Cash Flow

$30.69M

Capital Expenditure

$57.00K

Free Cash Flow

$30.75M

Cash & ST Invst.

$16.80M

Total Debt

$106.00K

Apexigen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

11

N/A

Net Income

$6.05M

+99.6%

EBITDA

$6.16M

+99.7%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$9.37M

+101.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.38%

N/A

Return on Invested Capital

-5.12%

N/A

Free Cash Flow

$3.00M

+99.3%

Operating Cash Flow

$3.00M

+99.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMVIFIMV Inc.
$0.00+0.00%
SCPXScorpius Holdings, Inc.
$0.01-3.17%
BTHEBoston Therapeutics, Inc.
$0.01+0.00%
TSBXTurnstone Biologics Corp.
$0.35+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.15-0.03%
ANNAAleAnna
$6.98+0.84%
INTCIntel
$45.31-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.56+0.03%

Questions About APGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.